Crossmark

3′,4′-Dihydro-2′H-spiro[indoline-3,1′-isoquinolin]-2-ones as potential anti-cancer agents: synthesis and preliminary screening

Published Online: 2020-01-08

Published Print: 2020-01

Authors

Lobe, Maloba M. M.

Efange, Simon M. N.
Funding

Funding for this research was provided by:

Ministry of Higher Education, Cameroon - Modernization of Research Scheme (2017-2019)
License Information

Text and Data Mining valid from 2020-01-01
More Information

Publication History

Received: 2019-07-29

Accepted: 2019-11-19

Published: 2020-01-08

Document is current